Genentech’s Actemra Becomes the First Biologic Therapy Approved by the FDA for Slowing the Rate of Decline in Pulmonary Function in Adults With Systemic Sclerosis-Associated Interstitial Lung ...

Pediatric patients with cystic fibrosis hospitalized with an exacerbation showed no lung function improvement with systemic corticosteroids, according to study results published in Annals of the ...

There are two types of systemic risk that can infect the highly interconnected global banking system.

Non-pharmacological strategies such as exercise can improve hand function in patients with systemic sclerosis, according to data published in the International Journal of Rheumatic Diseases.